Herbalife Nutrition Ltd vs Honeywell International Inc — how do they compare? Herbalife Nutrition Ltd trades at $12.05 (market cap $1.27B), while Honeywell International Inc trades at $229.58 (market cap $71.66B). The key difference: Honeywell International Inc is far larger — about 56.4× Herbalife Nutrition Ltd's market cap, and Honeywell International Inc pays a 4.21% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| HLF | HON | |
|---|---|---|
Market Cap | $1.27B | $71.66B |
Sector | Consumer Staples | Industrials |
52-Week High | $19.96 | $248.04 |
52-Week Low | $7.75 | $188.14 |
Enterprise Value | $3.00B | $96.01B |
Dividend Yield | — | 4.21% |
Signals from Pluang's Aura AI — not financial advice
HLF trades at $12.04, up 0.42% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.64, beating expectations of $0.607, and raised full-year guidance. Revenue for 2025 was $5.04 billion with a net income margin of 4.66%, while valuation ratios remain low with a P/E of 5.38 and P/S of 0.25. Recent news includes Herbalife's inclusion in TIME's America's Best Companies 2026 and a $1.45 billion debt refinancing completed in April 2026.
The outlook for HLF is cautiously optimistic due to strong earnings beats and strategic initiatives, but risks include high debt levels and competitive pressures. Analyst consensus is 57.69% buy, with institutional sentiment leaning positive amid ongoing business transformation efforts.
Honeywell International (HON) trades at $229.86, up 2.15% with a bullish technical signal and strong analyst support. The company maintains solid profitability with 10.89% net margin and 26.41% ROE, though recent earnings show some pressure with Q2 2026 expectations at $1.80 EPS. Recent developments include a completed 2:1 reverse stock split and the acquisition of Johnson Matthey's Catalyst Technologies business for £1.325 billion, positioning the company for growth in automation and industrial technology.
HON presents a compelling investment case with 65% analyst buy ratings and a $368.55 consensus price target representing 60% upside. However, risks include declining profit margins (12.63% in 2025 vs 14.81% in 2024), increasing debt-to-asset ratio (46.65% in 2025), and near-term earnings uncertainty post-spinoffs. The stock's valuation at 18.07 P/E appears reasonable given its market leadership and strategic repositioning.
Trailing returns across standard periods
Latest headlines on both assets
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →